pharmaceutical
GSK withdraws from running for Pfizer Consumer Health
March 23, 2018Medical Communications, Sales and Marketing GSK, Pfizer, Pfizer Consumer Health, biotech, drugs, pharma, pharmaceutical
GSK has announced that it has decided to pull out of the race to acquire Pfizer’s Consumer Health business, ending …
Regeneron-Alnylam team up to treat NASH
March 22, 2018Research and Development, Sales and Marketing Alnylam, Regeneron, biotech, drugs, nash, pharma, pharmaceutical
Coming on the back of a Regeneron research piece published in the New England Journal of Medicine, the company announced …
Bayer-Monsanto deal one step closer, after EU nod
March 22, 2018Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical
The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …
Sun Pharma receives approval for first biologic drug
March 22, 2018Sales and Marketing Sun Pharma, biotech, drugs, pharma, pharmaceutical
The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as …
Independent committee report seeks Brexit healthcare clarity
March 21, 2018Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical
An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
J&J’s longest-standing CFO finally steps down
March 21, 2018Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical
Johnson & Johnson have revealed that its Chief Financial Officer and Executive Vice President, Dominic J. Caruso, will retire from …
Celgene bucks trend to strengthen neuroscience pipeline
March 21, 2018Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical
Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …
Novartis steps into the medical marijuana business
March 20, 2018Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical
Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …
Roche’s immunotherapy improves PFS but unclear long-term benefit in lung cancer
March 20, 2018Manufacturing and Production, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market …
Vertex “astonished” by NHS England’s response to CF drug
March 20, 2018Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical
Vertex has been battling to have its treatment, Orkambi, approved in the UK since 2016, when it was first rejected …
Male contraceptive pill hits safety goals
March 19, 2018Research and Development, Sales and Marketing biotech, drugs, male contraceptive, pharma, pharmaceutical
A male contraceptive pill may be edging closer to the market, after a new formulation was shown to be safe …
Lundbeck takes risk on Parkinson’s treatment, €905m on table
March 19, 2018Sales and Marketing Lundbeck, Parkinson's, biotech, drugs, pharma, pharmaceutical
CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …
Pfizer to hang onto CEO, after 61% pay increase
March 19, 2018Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …
Rising levels of opioid prescriptions puts NHS under pressure
March 16, 2018Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical
It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …
Allergan navigating choppy waters, as shares rise and fall
March 16, 2018Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical
By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
